Dr Giulia Terribile is a Post-Doc Researcher in the Human Physiology Unit at the School of Medicine and Surgery, University of Milano-Bicocca, where she also completed her PhD studies in Experimental Neuroscience in 2023. After obtaining her MSc degree in Pharmacy at the University of Milan (2018), she obtained her license to practice as a Pharmacist (2018). From 2017 to 2018 she carried out her internship at the Institute of Neuroscience of the National Research Council of Italy (IN-CNR) in Milan, where she was involved in characterizing the metabolism of microglia with different phenotypes. From 2018 to 2019, she worked as a research fellow at the IRCCS - Pharmacological Research Institute Mario Negri, where she was involved in characterizing the role of p97 in muscle atrophy induced by cancer and amyotrophic lateral sclerosis. She has developed strong competence in various laboratory techniques (ranging from cell culture to molecular biology, electrophysiology, calcium imaging and animal handling). Her expertise is mainly related to physiological characterization of pathways involved in pathological processes, blood-brain barrier models, interaction of engineered nanoparticles with elements of the neurovascular unit and characterization of atmospheric particulate matter effects on the central nervous system (linked to neuroinflammation and neurodegeneration). She is currently a member of the Italian Physiology Society (SIF) and the Italian society for Neuroscience (SINS).